The future of precision medicine: at the forefront of advances in genomics
Our mission at Euformatics is to accelerate the transition to precision medicine. But what exactly does that mean? And how does NGS software from a
PRESS RELEASE | Euformatics receives funding from Amazon Web Services and is selected by SYNLAB to design and deploy cloud-based genomic variant analysis software including COVID-19 variant surveillance
HELSINKI, Finland, August 2021. Finnish bioinformatics software company Euformatics has been awarded funding through the Amazon Web Services (AWS)
PRESS RELEASE | Euformatics further expands channel partner network through agreement with Quimiolab, Colombian distributor of NGS technologies
HELSINKI, Finland, July 2021. Euformatics, a bioinformatics software company providing world-leading NGS interpretation and quality control tools
PRESS RELEASE | Euformatics partners with Solaria Biodata, Mexican company specialised in bioinformatics solutions
HELSINKI, Finland, July 2021. Euformatics, a bioinformatics software company providing world-leading NGS interpretation and quality control tools
PRESS RELEASE | King Chulalongkorn Memorial Hospital chooses Omnomics Suite from Euformatics for NGS QC and analysis software as test offering expands
HELSINKI, Finland, July 2021. King Chulalongkorn Memorial Hospital in Bangkok, Thailand, has chosen Finnish software company Euformatics as the
PRESS RELEASE | Euformatics and Kemomed in distribution partnership for world-leading NGS bioinformatics software in Slovenia and Croatia
HELSINKI, Finland, July 2021. Finnish bioinformatics software company Euformatics, which develops and sells world-leading NGS interpretation and
PRESS RELEASE | Euformatics in distribution agreement with Illumina reseller in Indonesia, PT Pandu Biosains
HELSINKI, Finland, July 2021. Finnish bioinformatics software company Euformatics, which develops and sells world-leading NGS interpretation and
